Ajaya
1 known investors
Ajaya develops precision antibodies designed to selectively remove disease-causing immune cells while preserving healthy immune function, targeting autoimmune disease treatment.
Biotech
Investors · 1
In the news
- Commercial papers explained: How companies raise short-term funds | Company News - Business Standardbusiness-standard.com · 2026
- Ajaya Bio plans Series A to advance autoimmune treatment and grow in Philadelphiatechnical.ly · 2026
- Payments firm Juspay raises $60 mn days after open-sourcing routing layer | Company News - Business Standardbusiness-standard.com · 2025
- CURRYiT has raised INR 4.5 Cr in Seed funding round co-led by RK Family Trust, Tangent Advisors, and Freeflow Ventures. - Enablersenablersinvestment.com · 2024
- CURRYiT raises Rs 4.5cr in seed round to scale-up manufacturing & distributionbusiness-standard.com · 2024